Safwan Kezbor

Accomplished strategic thinker research physician and medical monitor with extensive experience in the global pharmaceutical industry in multiple therapeutic areas. Over a decade of clinical research and drug development experience in the pharmaceutical industry, CRO, and academia. Experienced in a broad range of functional areas including Clinical Development from First-in-human (Phase 1) through post-marketing, clinical studies design, PROs, Medical Monitoring, CSRs execution, and regulatory involvement with multiple regional health authorities (e.g., FDA, EMA, PMDA). Track record of results-oriented high-performance demonstrated in developing, executing and monitoring complex clinical studies to deliver high-quality strategic outcomes.

Therapeutics areas of expertise: oncology, neurology, cardiovascular, ophthalmology, rare disease, paediatrics, gene therapy, immunology, NASH, general internal medicine.

Clinical Trials experience Phase I (First-In-Human, Dose-escalation, Drug-Drug interaction, Food interaction, bioavailability), Phase II, Phase III confirmatory, post-marketing registry studies. Pregnancy registry and paediatrics studies.

Speaker Details
Events of the Speaker
You might also love these events.
Meridian Clinical Trials - Presentation
November 22, 2021
5th Meridian Clinical Trials is a nexus of the clinical trials industry for networking, knowledge sharing, collaboration, and partner outreach. MCT partners with leading research institutions, private pharma-biotechs, and contract research organizations to stay updated about the latest scientific knowledge, research, and technology.